(Total Views: 240)
Posted On: 02/10/2019 10:16:55 PM
Post# of 149545
yes, trding. We had it in text form on the napkin so far to compare against R&R's valuation which used that.
I would love they license our or sell HIV-1 indication (upfront + royalty based) and then go full cancer etc.
The 100% original valuation is good to see the big picture, also buyout value.
Maybe a mix & match.
I would love they license our or sell HIV-1 indication (upfront + royalty based) and then go full cancer etc.
The 100% original valuation is good to see the big picture, also buyout value.
Maybe a mix & match.
(0)
(0)Scroll down for more posts ▼
